Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
HLA-A*11:01 (25–305)
AviHis加载中…
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| HLA-A*11:01 | HLAA1101-HP004 | Human | HEK293 | Human Peptide Ready HLA-A*11:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| KRAS G12D | KRASG12D-HP010 | Human | HEK293 | KRAS G12D (25–305) AviHis | |
| NY-ESO-1 | NYESO1-HP008 | Human | HEK293 | Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| MAGE-A4 | MAGEA4-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| KRAS G12V | KRASG12V-HP004 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| CMV pp65 | CMVPP65-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CMV pp65 (25–305) AviHis |
| KRAS G12D | KRASG12D-HB001 | Human | HEK293 | Biotinylated Human KRAS G12D TCR&CD3 Complex Nanodisc Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D His |
| CMV pp65 | CMVPP65-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CMV pp65 (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HP003 | Human | HEK293 | Human HLA-A*11:01&B2M&RASL11B (AVVGASGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| HLA-A*31:01 | HLAA3101-HP001 | Human | HEK293 | Human Peptide Ready HLA-A*31:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg | HLA-A*31:01 (25–305) AviHis |
| HPV16 E7 | HPV16E7-HP001 | Human | HEK293 | Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HP006 | Human | HEK293 | HLA-A*11:01 (25–305) AviHis | |
| CD8 | CD8-CB002 | Cynomolgus | HEK293 | Biotinylated Cynomolgus CD8 alpha&beta Heterodimer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CD8 (22–182) AviHisFLAG |
| KRAS G12V | KRASG12V-HP002 | Human | HEK293 | Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| MAGE-A10 | MAGEA10-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A10 (GLYDGMEHL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A10 (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HP005 | Human | HEK293 | Human Peptide Ready HLA-E*01:03&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| KRAS G12S | KRASG12S-HP001 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12S (25–305) AviHis |
| HPV16 E7 | HPV16E7-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |
| EGFR L858R | EGFRL858R-HB003 | Human | HEK293 | Biotinylated Human HLA-A*33:03&B2M&EGFR L858R (HVKITDFGR) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | EGFR L858R (25–305) AviHis |
| KRAS WT | KRASWT-HP005 | Human | HEK293 | Human HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS WT (25–305) AviHis |
